Granata Bio ("Granata"), a U.S.-based biotechnology company focused on advancing fertility therapeutics, today announced a strategic partnership with Gedeon Richter Plc. ("Richter"), a global leader ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today provides a strategic update on the ...

"The difference between living or dying can rest on whether or not the doctor knows about a particular condition." ...

The president signed an executive order Friday calling for several sweeping changes in VA operations and construction goals.

The Oncology Institute's stock surged 900% amid insider buying, despite cash burn, unprofitability, and potential need for ...

Social media is awash with content promoting grounding mats and sheets. Could they really help you sleep better?

Discover Agenus Inc.'s Q1 2025 highlights, including groundbreaking BOT/BAL data, strategic transactions, financial updates, and insights on ...

The guidance statements are the first developed to provide pediatric rheumatologists with recommendations for screening ...

Cosmetic injectables are big business in Australia with patients willing to hand over large sums of money, out of pocket, to ...

Company reports $74.1 million in Q1 total revenue, reflecting 61% growth year-over-year. IBSRELA net product sales revenue of $44.4 million; XPHOZAH net product sales revenue of $ ...

Pivotal Advance-HTN and Launch-HTN trials successfully achieved statistical significance in primary efficacy endpoints and demonstrated a favorable safety and tolerability profile – – Anticipate ...